Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ROS receptor tyrosine kinase: a new potential target for anticancer drugs.

Medicinal research reviews - 1 Sept 2011

El-Deeb Ibrahim Mustafa, Yoo Kyung Ho, Lee So Ha

Abstract excerpt

ROS kinase is one of the last two remaining orphan receptor tyrosine kinases with an as yet unidentified ligand. The normal functions of human ROS kinase in different body tissues have not been fully identified so far. However, the ectopic expression, as well as the production of variable mutant forms of ROS kinase has been reported in a number of cancers, such as glioblastoma multiforme, and non-small cell lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms
Share to Antineoplastic Agents
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infertility

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Proto-Oncogenes

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 20687158
DOI: 10.1002/med.20206

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ROS receptor tyrosine kinase: a new potential target for anticancer drugs.PMID 20687158Read ↗

Molecular pathways: ROS1 fusion proteins in cancer.Semantic proximity Read ↗

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitorsSemantic proximity Read ↗

ROS Fusion Tyrosine Kinase Activates a SH2 Domain–Containing Phosphatase-2/Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Signaling Axis to Form Glioblastoma in MiceSemantic proximity Read ↗

Epigenetic Regulation of c-ROS Receptor Tyrosine Kinase Expression in Malignant GliomasSemantic proximity Read ↗

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.Semantic proximity Read ↗

KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT PathwaySemantic proximity Read ↗

Mouse Model for ROS1-Rearranged Lung CancerSemantic proximity Read ↗

<i>ROS1</i> Fusions in Cancer: A ReviewSemantic proximity Read ↗

Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor AggressivenessSemantic proximity Read ↗

Blockade of redox second messengers inhibits JAK/STAT and MEK/ERK signaling sensitizing FLT3-mutant acute myeloid leukemia to targeted therapiesSemantic proximity Read ↗

Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion.Semantic proximity Read ↗

Ribosomal S6 kinase as a mediator of keratinocyte growth factor-induced activation of Akt in epithelial cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.